JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A1894 SL-327
1 Citation

Target: MEK

Summary: Selective MEK1/2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥16.75 mg/mL
A2678 SU11274
2 Citation

Target: MET

Summary: C-Met inhibitor,potent and selective

≥28.4 mg/mL
A1792 PD184352 (CI-1040)

Target: MEK

Summary: Selective MEK inhibitor

≥47.9 mg/mL
A1425 Losartan Potassium (DuP 753)

Summary: Angiotensin AT1 receptor antagonist

≥45.95 mg/mL
A2436 Fluoxetine HCl

Target: Serotonin (5-HT) reuptake

Summary: Serotonin reuptake inhibitor,selective

insoluble in H2O; ≥17.3 mg/mL
A2553 Fluvoxamine maleate

Summary: Serotonin reuptake inhibitor,selective,antidepressant

≥21.72 mg/mL
A1945 BIBR 1532
2 Citation

Target: telomerase

Summary: Telomerase inhibitor,novel and selective

insoluble in H2O; ≥15.65 mg/mL
A2306 Ellagic acid

Summary: Casein kinase 2 (CK2) inhibitor

insoluble in H2O; insoluble in EtOH; ≥3.78 mg/mL
A1971 Etoposide
4 Citation

Target: Topoisomerases

Summary: DNA topoisomerase II inhibitor

≥112.6 mg/mL
A1373 Biapenem

Summary: Highly broad spectrum antibiotic agent

≥18.65 mg/mL